How to Build a Peptide Recovery Protocol

You understand the theory. You have read about BPC-157, TB-500 and IGF-1 LR3. You know that these compounds have compelling research behind them and that athletes around the world are using them to recover faster and more completely from injury and training.

But theory and practice are different things. How do you actually put together a protocol that makes sense for your situation?

This guide walks you through the process of building a peptide recovery protocol from the ground up, covering how to assess your needs, which compounds to prioritise, how to structure dosing and what to track along the way.

Step 1: Define What You Are Trying to Recover From

This might seem obvious, but it is the most important step and the one that most shapes every decision that follows. Recovery is not a single thing. The right protocol for a runner with chronic Achilles tendinopathy looks quite different from the right protocol for a powerlifter recovering from a pectoral tear.

Ask yourself the following questions before anything else:

Is this an acute injury or a chronic one?
Acute injuries are recent, typically within the past four to six weeks. Chronic injuries have been present for months or years and have often partially healed, then recurred or plateaued. The two require somewhat different emphasis.

What tissue type is primarily affected?
Muscle injuries respond differently from tendon injuries, which respond differently from joint and ligament injuries. Understanding what you are working with helps you choose compounds with the most relevant mechanisms.

Is inflammation the primary problem, or is the issue more about incomplete structural repair?
Some injuries involve ongoing active inflammation that keeps the area painful and limits function. Others involve tissue that has healed improperly or incompletely. These different situations call for different emphases.

What is the timeline pressure?
Someone with a competition in eight weeks has different protocol requirements than someone with a chronic issue and no particular deadline. A more aggressive loading approach may be appropriate for the former; a longer, steadier protocol may be better for the latter.

Step 2: Match Your Situation to the Right Compounds

Once you have clarity on what you are recovering from, you can make more informed compound choices.

For tendon and ligament injuries:
BPC-157 should be the anchor compound. Its specific effects on tendon fibroblasts and its angiogenic properties are directly relevant. TB-500 adds systemic healing support and enhanced cell migration. This combination (the Wolverine Stack) is the most well-supported starting point for connective tissue injuries.

For muscle injuries and tears:
TB-500 is particularly relevant given its actin-binding mechanism and satellite cell support. BPC-157 adds angiogenic and anti-inflammatory support. For more significant muscle injuries where maximum anabolic signalling is the goal, IGF-1 LR3 can be considered as an addition, though it warrants more careful protocol design.

For joint issues and cartilage concerns:
TB-500 has the more relevant research profile for cartilage (chondrocyte effects). BPC-157 contributes through its anti-inflammatory mechanisms. If significant inflammation is the primary issue, leading with BPC-157 and layering TB-500 makes sense.

For post-surgical recovery:
The full Wolverine Stack (BPC-157 + TB-500) is appropriate as a foundation. The timing relative to surgery should be discussed with your surgeon or a knowledgeable practitioner. IGF-1 LR3 can be considered for more complex or extensive surgical repairs where maximising tissue regeneration is the priority.

For general training recovery without a specific acute injury:
BPC-157 alone is often a reasonable starting point. It addresses the ongoing microtrauma, inflammation and connective tissue stress that accumulates under heavy training loads. Adding TB-500 during particularly demanding training blocks makes sense.

Step 3: Know the Limits of the Evidence

Before choosing anything, be clear about what the research can and cannot tell you:

• BPC-157: almost entirely animal studies; no controlled human trials.
• TB-500: animal and cell studies for the fragment; the human trials used full thymosin beta-4, a different molecule.
• IGF-1 LR3: potent, unapproved for any medical use, and affects blood glucose.
• Combinations: none of these stacks has been studied as a combination.

Any injury that is severe, not improving or affecting daily function belongs with a doctor or physiotherapist first. They can rule out what a peptide cannot fix, such as a full tear that needs surgical repair.

Step 4: Support the Protocol with the Right Lifestyle Inputs

Peptides are not a substitute for the fundamentals. They enhance a recovery environment that the fundamentals create. Without these inputs, you are leaving a significant portion of the potential benefit on the table.

Protein intake
Tissue repair is a protein-dependent process. Every repair mechanism discussed in this series, from collagen synthesis to satellite cell activity to protein synthesis, requires adequate amino acid availability. Aim for at least 1.6 to 2g of protein per kilogram of body weight per day during a recovery phase. This is non-negotiable.

Sleep
The majority of growth hormone is secreted during deep sleep, and GH drives IGF-1 production, which in turn supports the repair cascades that peptides like BPC-157 and TB-500 are designed to enhance. If sleep quality is poor, you are limiting the hormonal foundation for recovery regardless of what peptides are in your protocol.

Appropriate activity
Complete immobilisation is rarely optimal for recovery. Controlled, progressive loading of healing tissue (guided by pain response and ideally by a physiotherapist) signals the tissue to align properly during repair and prevents the development of weak, disorganised scar tissue. Peptides support this process; they do not replace the mechanical stimulus.

Anti-inflammatory nutrition
Chronic dietary inflammation, driven by highly processed foods, excess refined carbohydrates and poor omega-3 to omega-6 ratios, can work against the recovery environment you are trying to create. This does not require extreme dietary changes, but attention to food quality during a recovery phase is worth the effort.

Step 5: Track Your Progress Honestly

Recovery is not always linear and it is easy to either overestimate or underestimate how things are going. Keeping a simple log helps.

Track the following throughout a recovery phase:

• Pain level at the injury site on a 1 to 10 scale, at the same time each day
• Range of motion or functional markers specific to your injury (how far you can bend a knee, whether you can perform a specific movement pain-free)
• Sleep quality and duration
• Training load and how the injury responds to activity
• Any side effects or unusual symptoms

Review this log weekly. Patterns over weeks are more meaningful than day-to-day fluctuations. If you are four weeks in and seeing no measurable change across any of these markers, that is the point to get the injury properly assessed.

When to Seek Professional Input

Peptide protocols are most effective when designed around a clear understanding of the underlying injury. If you do not have a diagnosis for your injury, getting one before building a protocol is worthwhile. Knowing whether you are dealing with a partial tendon tear, a complete ligament rupture, a stress fracture or a muscle strain significantly affects both the protocol design and the realistic expectations for recovery timeline.

A sports medicine doctor, physiotherapist or GP familiar with peptide therapy can add meaningful value to this process. The peptide research community and our team at STRIATA can also help you think through options, though we are not a substitute for professional medical assessment.

If you want to talk through your specific situation, reach out on WhatsApp. We are happy to help you understand your options without pressure.

Sources

The research, regulatory documents and clinical guidelines behind the claims in this article:

• Staresinic M, Sebecic B, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research, 2003.
• Chang CH, Tsai WC, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 2011.
• Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta-4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine, 2005.
• Philp D, Huff T, et al. The actin binding site on thymosin beta-4 promotes angiogenesis. FASEB Journal, 2003.
• Blain EJ, Mason DJ, Duance VC. The effect of thymosin beta-4 on articular cartilage chondrocyte matrix metalloproteinase expression. Biochemical Society Transactions, 2002.
• Schiaffino S, Mammucari C. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skeletal Muscle, 2011.
• Morton RW, Murphy KT, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British Journal of Sports Medicine, 2018.

Disclaimer: The information in this article is for educational purposes only. STRIATA peptides are research compounds and are not approved medicines. Always consult a qualified healthcare professional before beginning any protocol, particularly for serious or post-surgical injuries.